Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction
Simeng Liu, Yanggang Yuan, Yi Xue, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
Xiandeng Li, Ying Zhang, Xiaodong Xing, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115670-115670
Open Access | Times Cited: 44
Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
Fugang Huang, Shuo Huang, Ke Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease
Qian Shen, Ji Fang, Hengjiang Guo, et al.
Free Radical Biology and Medicine (2023) Vol. 203, pp. 45-57
Open Access | Times Cited: 42
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway
Chenlei Lv, Tianyang Cheng, Bingbing Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 31
Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
Can Yang, Zhen Zhang, Jieting Liu, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 27
Poricoic acid A induces mitophagy to ameliorate podocyte injury in diabetic kidney disease via downregulating FUNDC1
Yuwen Wu, Haohua Deng, Jiazhong Sun, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 15
STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease
Xueyan Yang, Zhaowei Chen, Zilv Luo, et al.
Cellular Signalling (2023) Vol. 109, pp. 110777-110777
Closed Access | Times Cited: 14
(Pro)renin receptor mediates tubular epithelial cell pyroptosis in diabetic kidney disease via DPP4-JNK pathway
Shiying Xie, Shicong Song, Sirui Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
FTO‐mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF‐κB signaling pathway
Yating Lang, Qimeng Wang, Qinghao Sheng, et al.
The FASEB Journal (2024) Vol. 38, Iss. 2
Open Access | Times Cited: 6
Mechanisms and implications of podocyte autophagy in chronic kidney disease
Rachel Njeim, Sandra Merscher, Alessia Fornoni
AJP Renal Physiology (2024) Vol. 326, Iss. 6, pp. F877-F893
Closed Access | Times Cited: 6
SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
Wenxiu Qi, Cheng Hu, Daqing Zhao, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2
Donghee Kim, Ka-Yun Ban, Geon-Ho Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9968-9968
Open Access | Times Cited: 12
RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling
Jeong Suk Kang, Namjun Cho, Seong Woo Lee, et al.
Metabolism (2024) Vol. 159, pp. 155982-155982
Closed Access | Times Cited: 4
Mitochondria-associated endoplasmic reticulum membranes promote mitochondrial fission through AKAP1-Drp1 pathway in podocytes under high glucose conditions
Xue Li, Qinglan Yang, Sirui Liu, et al.
Experimental Cell Research (2023) Vol. 424, Iss. 2, pp. 113512-113512
Closed Access | Times Cited: 11
Combine Therapy of Gallic Acid and Allicin in Management of Diabetes
Roshan Kumar, Prachi Sood, Vinod Rana, et al.
Journal for Research in Applied Sciences and Biotechnology (2023) Vol. 2, Iss. 3, pp. 91-99
Open Access | Times Cited: 10
Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism
Tong‐Tong Liu, Qi Jin, Liping Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Integrative analysis of mitochondrial and immune pathways in diabetic kidney disease: identification of AASS and CASP3 as key predictors and therapeutic targets
Xin‐Xin Yu, Yongzheng Hu, Wei Jiang
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018
Xiaoxia Pang, Wenchao Dan, Lan Lin, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Alstonia scholaris (L.) R. Br. ameliorated diabetic nephropathy through PPAR-δ pathway
Shi-Shi Qin, Cai-Bo Tian, Yan-Ling Qian, et al.
Journal of Ethnopharmacology (2025) Vol. 348, pp. 119839-119839
Closed Access
Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy
Jian Lu, Xue Qi Li, Pei Pei Chen, et al.
JCI Insight (2023) Vol. 8, Iss. 20
Open Access | Times Cited: 9
Promoting mitochondrial dynamics by inhibiting the PINK1–PRKN pathway to relieve diabetic nephropathy
Jun‐yi Zhu, Joyce van de Leemput, Zhe Han
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 3
miR‐4645‐3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5
Y P Zhang, Shunjie Xia, Xiaoxi Tian, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 3
Effects of Inonotus obliquus on ameliorating podocyte injury in ORG mice through TNF pathway and prediction of active compounds
Zhaodi Han, Le Gong, Yani Xue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
Yuting Li, Jiaojiao Fan, Wenping Zhu, et al.
Kidney Diseases (2023) Vol. 9, Iss. 4, pp. 254-264
Open Access | Times Cited: 8
Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease
J. H. Baek, Yu Ho Lee, Hye Yun Jeong, et al.
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 5, pp. 564-560
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top